Simulation results revealed a detailed consequence of the Pro12Ala mutation on the PPARγ2 protein that may provide insight for therapeutic approaches, especially in T2DM and CAD or NAFLD. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.